Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-4 of 4
Keywords: therapeutic agent
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies
Available to Purchase
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2012) 40 (4): 661–666.
Published: 20 July 2012
... M.J. Hogan A.L. Trojanowski J.Q. Smith A.B. 3rd Lee V.M.Y. The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies Pharmacol. Res. 2011 63 341 351 49 Beer T.M. Higano C.S. Saleh M...
Articles
mTOR: dissecting regulation and mechanism of action to understand human disease
Available to Purchase
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2009) 37 (1): 213–216.
Published: 20 January 2009
... interest and accelerating progress in dissecting out the control and functions of mTOR. amino acid sensing autophagy protein kinase mammalian target of rapamycin (mTOR) therapeutic agent The timely ‘mTOR Signalling, Nutrients and Disease’ meeting brought together groups with shared interests...
Articles
Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges
Available to Purchase
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2007) 35 (4): 737–741.
Published: 20 July 2007
... profiles of these bivalent ligands, which remain to be investigated, could lead to highly novel research tools and potential therapeutic agents. In the human V 2 R, inverse agonists acting at the receptor can lead to ligand-selective receptor activation, as shown by Azzi et al. [ 35 ]. In HEK-293 (human...
Articles
NGF receptor TrkAd5: therapeutic agent and drug design target
Available to PurchaseD. Dawbarn, M. Fahey, J. Watson, S. Tyler, D. Shoemark, R. Sessions, R. Zhang, L. Brady, C. Willis, S.J. Allen
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2006) 34 (4): 587–590.
Published: 21 July 2006
... of inflammatory pain and asthma by the sequestration of excess levels of endogenous NGF, and therefore represents a novel therapeutic agent. 1 To whom correspondence should be addressed (email [email protected] ). 26 4 2006 NGF (nerve growth factor) was originally thought...